The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Bought 100.000@7.75 shares end of March last year, top-sliced in Nov @66. Bought another 50.000 in Dec @17, got a massive dividend and top-sliced again @120. Free-riding over 80.000 shares with a nice profit taken. Sorry for all RMS losers, you bet on the wrong horse...
Since BRH is an investment company there has been a lot of discussions on how to proceed once all tests have been completed for both Covid-19 and Alzheimers.
Well, from the Paraytecs point of view it's already clear:
Paraytec developed the award winning ActiPix™ brand of ultra-violet (UV) area imaging detectors. These systems use either single or multiplex capillary cartridges or specialised imaging cells for use in a variety of life science application areas.
The Company has developed its unique patented technology over a number of years and has pursued a strategy of forming partnerships with international companies, such as Malvern Instruments and Pion Inc to manufacture and distribute its image detectors worldwide.
Even better, Gold Standard+ with their additional comparator
From the RNS:
The current gold standard for estimation of viral load continues to be laboratory-based PCR tests. However, these detect viral RNA levels and not necessarily the presence of infectious virions, which means that many patients test positive, long after they are no longer infectious. Paraytec has thus adopted an additional comparator test developed by the University of Sheffield, to verify the presence of intact virus particles. This involves ultracentrifugation and high-resolution fluorescence microscopy to independently verify the presence of virions in clinical samples.
In parallel to the sample processing described above, the Paraytec team has been using isolated lab-grown virus to optimise the operational sensitivity of its instrument for the detection of pre-symptomatic and early-stage symptomatic virus levels. It believes it will be able to confirm, within a period of four weeks, a lower limit of detection of 1,000 virions per millilitre of sample, also a market-leading value.
http://www.velatechplc.com/
It's all on their website, velatechplc.com
I know it sounds terrible, but hoping for another red day. Tomorrow is the BRH dividend payout and my aim is to double up on SYME (from 5m to 10m shares). Is it too much to ask for a little deramping today, team ?? This is one of my LTH in my sipp, so no trader. Have a nice day all, and keep safe